PACB icon

Pacific Biosciences
PACB

Overview Fund Activity

272 hedge funds and large institutions have $2.2B invested in Pacific Biosciences in 2023 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 91 increasing their positions, 86 reducing their positions, and 40 closing their positions.

Holders
272
Holders Change
+2
Holders Change %
+0.74%
% of All Funds
4.34%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
43
Increased
91
Reduced
86
Closed
40
Calls
$101M
Puts
$24.8M
Net Calls
+$76.1M
Net Calls Change
+$54M

Top Buyers

1
DTC
1
Deep Track Capital
Connecticut
$50.1M
2
AIM
2
ARK Investment Management
Florida
$249M
3
VS
3
VK Services
California
$22M
4
Bank of New York Mellon
4
Bank of New York Mellon
New York
$36.8M
5
FCM
5
Farallon Capital Management
California
$85.4M

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$21.7M
2
APM
2
Avidity Partners Management
Texas
$8.64M
3
SIG
3
Senator Investment Group
New York
$0
4
JSP
4
Jackson Square Partners
California
$57.9M
5
Victory Capital Management
5
Victory Capital Management
Texas
$5.45M
Name Holding Trade Value Shares
Change 		Shares
Change %
FBC
301
Fairfield, Bush & Co
Connecticut
– -$26.6K -2,000 Closed
SOW
302
State of Wyoming
Wyoming
– -$5.4K -406 Closed
TWC
303
TD Waterhouse Canada
Ontario, Canada
– -$3.96K -225 Closed
IPW
304
Impact Partnership Wealth
Georgia
– -$1.81K -136 Closed
GI
305
Gradient Investments
Minnesota
– -$798 -60 Closed
VCM
306
Versant Capital Management
Arizona
– -$638 -48 Closed
DI
307
Disciplined Investments
Oklahoma
– -$106 -8 Closed
9 10 11 12
13